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ABSTRACT
In patients diagnosed with Amyotrophic Lateral Sclerosis (ALS), the

primary pathological cause of death, as determined by autopsy, is pneumonia.
Research associates poor oral health with an increased incidence of pneumonia.
The incidence is further elevated in mechanically ventilated, disabled and high‐risk
individuals. A proactive approach in oral health care could mitigate the risk of
pneumonia related deaths in patients with ALS. This study evaluated whether the
dental needs of ALS patients were being met.
Over a three‐month period 121 ALS patients were surveyed regarding their
oral health status. Both written and online survey formats were employed. ALS
Association Multidisciplinary Clinics and Certified Centers assisted in survey
promotion and distribution. Research results were analyzed utilizing bivariate
Pearson correlation coefficients to determine relationships among study variables.
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Results showed patients’ difficulty in obtaining dental health care increased
by 38.7% when the responsibility of their oral health care transitioned from patient
to caregiver. Also increasing the difficulty in obtaining dental health care was the
length of time elapsed since patient diagnosis. An overwhelming 85% of patients
responded that they had not received dental health care information at their
multidisciplinary clinic appointments.
Educating patients, their caregivers and ALS medical support personnel on
the significance of oral health care and its association with pneumonia and
pneumonia related death could have a positive impact on ALS patient life
expectancy. This study supports the need for inclusion of a dental component into
ALS patients’ multidisciplinary clinic appointments.
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Chapter 1: Introduction
Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, is a
degenerative, fatal neuromuscular disease. Each year in the United States 5600
people are newly diagnosed. There is no known cure. From date of diagnosis
typical life expectancy is three to five years. During that time the patient steadily
deteriorates from a functional state into a completely paralyzed, fully dependent
lifestyle. Pneumonia induced respiratory failure is the leading cause of death.1 It is
speculated that, as their disease advances, patients with ALS often find maintaining
oral health quickly becomes a challenge. Recent studies associate poor oral hygiene
and periodontal disease with colonized oropharyngeal respiratory pathogens that,
when aspirated, may induce pneumonia.3 Therefore, ALS patients with insufficient
oral health and to an even higher degree, patients opting for mechanical ventilation
are at an increased risk for developing life‐threatening pneumonia. Research also
supports the hypothesis that, in these susceptible patients, oral and dental health
education can reduce the incidence of pneumonia.21 As the disease progresses and
oral health care responsibilities transition to the caregiver(s) dental hygiene
education and instruction become pivotal to the patient’s well‐being.

Statement of the Problem
As ALS patients’ motor skills decline the level of difficulty in performing
activities of daily living (ADL) and obtaining medical care increases. Not only is it an
obstacle for the patient but, finances, transportation and treatment scheduling also
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complicate the matter for caregivers. Dental health care and oral hygiene, initially
maintained by the patient now become the responsibility of the caregiver.
Poor oral hygiene and periodontal disease have been positively linked with
pneumonia, the leading cause of death in ALS patients.3 Studies have also shown a
reduction in pneumonia associated with poor oral health when preventative oral
hygiene procedures are performed.3 Therefore, it is imperative that the ALS patient,
as well as their caregivers, understand not only the significance of oral health but
are also trained in proper oral hygiene protocols. This research study was designed
to determine whether the dental health care needs of ALS patients are being met.

Significance of the Problem
There is no current research supporting the necessity of dental/oral health
treatment during the progression of ALS. Nor is there research that identifies the
varying levels of oral health care required by ALS patients throughout the course of
the disease.
As the ALS patients’ motor skills deteriorate, their ability to maintain oral
health care also declines. Additionally, caregivers may not be aware of the
significance of oral health in relationship to the specific needs of the patient. Oral
hygiene instruction tailored to the various stages of the disease is easily
disseminated; and the ALS patient’s primary caregiver is in the optimal position to
meet those needs.
Progressive weakening of the muscles utilized for eating, breathing, drinking
and swallowing creates additional obstacles for the ALS patient.52 Management of
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these symptoms may include ventilatory support. Non‐invasive bi‐level positive
airway pressure devices (or BiPAP®) machines are often incorporated at night for
respiratory relief. Tracheostomy and direct mechanical ventilation devices are two
additional treatment options, though seldom chosen by ALS patients.68,70
Regardless of the decision, all these options have profound effects on the oral cavity
and one’s ability to maintain dental health. Because the patient’s condition may
rapidly change, oral hygiene education needs to be provided to both the patient and
the caregiver.
Obtaining dental care at a dental facility often poses its own set of
complications. Not all dental practices are equipped to handle ALS patients in all of
their variant stages. Patients may have to seek care from a different provider or
forego dental treatment altogether. While changing health care providers can be
stressful to any person, to the patient with ALS, this process may prove to be
overwhelming and negatively influence their decision to seek care.
Evaluation of ALS patients’ dental needs is imperative in providing optimal
patient care. Assessing the patient’s current dental condition and oral health
knowledge may provide valuable information regarding whether the inclusion of a
dental component within ALS Association Multidisciplinary Clinics would be
beneficial.

Operational Definitions
Activities of Daily Living (ADL)
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Basic personal tasks in caring for oneself daily, for example, dressing, bathing and
eating.
Amyotrophic Lateral Sclerosis (ALS)
A chronic, progressive disease marked by gradual degeneration of the nerve cells in
the central nervous system that control voluntary muscle movement. The disorder
causes muscle weakness and atrophy. Symptoms commonly appear in middle to
late adulthood, with death in three to five years. The etiology is unknown, and there
is no known cure.
Upper Motor Neuron
Found in the motor cortex area of the brain, they send messages to lower motor
neurons to control skeletal muscle movement. Primarily involved with maintaining
muscle tone and initiation of voluntary muscle movement.
Lower Motor Neuron
Also known as anterior horn cells, they take messages from upper motor neurons to
control the muscle fibers they innervate.
Bilevel Positive Airway Pressure (BiPAP)
Mechanical ventilation designed to assist patients in moving air both into and out of
lungs.
Mechanical Ventilation
Machines used to assist or replace spontaneous breathing.
Invasive – Artificially supported ventilation provided through a cannula or
breathing tube placed directly into patient’s trachea.
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Noninvasive – Ventilatory assistance delivered via a nasal, oral/nasal or
full‐face mask designed to replicate patients’ normal respiration.
VentilatorAssociated Pneumonia (VAP)
Common complication causing significant morbidity and mortality in critically ill
patients, broadly defined as pneumonia developing more than 48 hours after
intubation.4
Durable Medical Equipment (DME)
Adaptive, reusable medical equipment used to improve patient comfort and/or
prolong patient independence. Must be medically necessary and prescribed by a
physician.
Assumptions
For the purpose of this investigation it is assumed that all patients surveyed
have been previously, positively diagnosed with clinical evidence of amyotrophic
lateral sclerosis and have provided honest, accurate responses regarding their
condition.
It is also assumed that articles and documents referenced in this
investigation utilized ethical and accurate methods to obtain and present factual
information.

Limitations
Despite numerous resources regarding amyotrophic lateral sclerosis, there
was limited information available on the number of ALS patients that elect for
mechanical ventilation, the type and extent of mechanical ventilation used and the
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length of time between a patient’s final clinic appointment and date of death.
Results indicating the number of ALS patients that choose to die at home in contrast
to a skilled care facility and whether the role of primary caregiver was familial or an
outside entity varied greatly, dependent upon the geographical region studied.
Initial survey results suggested time elapsed since patient diagnosis may
help indicate the individual’s current physical state. Collection of this information
was included in the amended electronic survey. Clarification of the patient’s degree
of mobility and level of self‐care at the time of survey may also prove valuable in
future studies.
Although five ALS Certified Centers agreed to participate with written survey
distribution and collection, the data from one location, Banner Good Samaritan
Medical Center of Phoenix Arizona, was not received in time to be included in
statistical analysis.

Methodology
A research study was conducted in which 121 ALS patients were surveyed
during a three‐month period from November 2010 through January 2011. Patients
were surveyed either in paper (written) format during routine ALS Association
Certified Center appointments or a secure website. Previously diagnosed ALS
patients who were 18 year of age or older were recruited. SPSS was employed for
statistical analysis. The University of New Mexico Human Research Review
Committee (HRRC), approved this study on Aug 16, 2010. Participant completion of
survey implied consent.
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Chapter 2: Review of Literature
Literature review was conducted by researcher using medical subject headings
(MeSH terminology) in PubMed/MEDLINE database from September 2010 –
January 2011. Cited references from previously published articles were also used to
locate additional resources.
MeSH terms:
Pulmonary infection/disease
Respiratory
Amyotrophic Lateral Sclerosis
Periodontal disease
Oral health/hygiene
Intubation
Mechanical ventilation
Pneumonia
Oral/dental hygiene education
Oral/dental hygiene instruction
Key words:
Respiratory, Amyotrophic Lateral Sclerosis, Periodontal, Oral hygiene, Pneumonia
Inclusion criteria:
Articles that evaluated correlations between ALS, respiratory conditions,
pneumonia, ventilation, dental/oral health and oral hygiene education/instruction
were reviewed.
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Exclusion criteria:
Search was limited to human studies.
The following measures were assessed:
Amyotrophic Lateral Sclerosis
Primary cause of death in ALS patients
Correlation between oral health and respiratory disease
Correlation between mechanically ventilated patients and respiratory disease
Reduction of respiratory complications through preventative oral health care,
education and instruction

Amyotrophic Lateral Sclerosis (ALS)
History
It was Jean Martin Charcot, a French physician and founder of modern
neurology who, in the 1870’s, first linked the symptoms of amyotrophic lateral
sclerosis to the group of nerves specifically affected by the disease.55 It is believed
Charcot employed a housemaid with ALS and was therefore able to systematically
observe the clinical manifestations of her disease. His meticulous observations and
descriptions of the disease remain accurate today. Throughout the world the disease
is known by different names. In parts of Europe the disease is still known as
Maladie de Charcot (Charcot’s disease). In the United States the disease is widely
recognized as ALS or Lou Gehrig’s disease; named after New York Yankees baseball
legend Lou Gehrig, who retired after being diagnosed in 1939. Until his death in
1941 Gehrig used his celebrity to promote awareness and educate the public about
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the disease.64 In 1993 the SOD1 gene on chromosome 21 was found to play a role in
some cases of familial ALS.65
Epidemiology
The annual incidence of ALS is one to two cases per 100,000 people. It is
estimated that, during any given time, 30,000 people in the United States have the
disease.9 Each year an average of 5600 Americans are newly diagnosed, the
equivalent of 15 people per day. The typical age of onset ranges from 40‐70 years of
age with the median age being 55. It is 20% more common in males and not
affected by racial, ethnic or socioeconomic status.9 From the date of diagnosis more
than 50% will live three to five years. Approximately 20% will live more than five
years, 10% more than ten years and 5% will live longer than twenty years.77
Etiology
A multitude of theories have postulated the etiology of ALS. However, to date,
none have proved statistically significant. Charcot first hypothesized a correlation
between poliomyelitis and the development of ALS. In 1907, SAK Wilson questioned
the roles of heavy metal involvement.11 Wilson’s theory gained momentum through
the early 1900’s until research showed mercury and lead, the leading suspects, were
capable of producing reversible ALS‐like symptoms. Since then, a host of prevailing
theories including dietary deficiency, environmental factors, physical injury64, toxic
exposure, vascular, immune and inflammatory disorders have been investigated
without substantiation.52 Current research leans toward a vast multifactorial
approach encompassing genetics, viral, autoimmune and neurotoxic hypotheses.61
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Clinical Features
ALS is a disorder of the motor neurons responsible for contracting the
skeletal muscles.11 In health, lower motor neurons, located in the brain stem and
spinal cord, innervate the muscle fibers. When a motor neuron fiber becomes
diseased it can no longer control the muscle it innervates and denervation occurs.
Consequently, the impaired muscle fibers shrink and the muscle becomes unable to
contract. If surrounding motor neurons are healthy they can regenerate nerve
fibers and take over control from the denervated fibers. Despite the overall
reduction in the number of motor neurons, as long as this process is maintained,
muscle strength remains constant.11
When the rate of denervation exceeds the rate of reinnervation, muscle
strength decreases. In more than half of ALS patients the progressive weakening of
muscles are among the first symptoms noted. Initial limb (arm or leg) weakness is
more common than bulbar onset; which involves muscles controlling speech and
swallowing.52 Typical signs of lower motor neuron degeneration include muscle
weakness, muscle atrophy, muscle cramping, fasciculations, paretic bulbar palsy
(dysarthria, dysphagia, sialorrhea), hyporeflexia and difficulty swallowing which
can lead to life‐threatening aspiration issues.66
Upper motor neurons are located in the brain and brain stem. They carry
information from brain centers that control the muscles of the body. These neurons
synapse with the lower motor neurons which transmit information to the muscles.12
Therefore, in order for motor commands generated in the central nervous system to
reach the muscles of the body, signals must utilize both the upper and the lower
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motor neurons. Upper motor neuron dysfunction progresses more slowly and
reveals itself in symptoms such as loss of dexterity, muscle spasticity, hyperreflexia
and spastic bulbar palsy.52
The type and degree of motor neuron onset are two of the main
characteristics utilized in diagnosing and classifying ALS.52 Another popular basis
used in classification is the method of acquisition.52 Ninety to ninety‐five percent of
patients have the sporadic form of ALS (SALS); ALS with no known familial history.
The remaining 5‐10% have familial ALS (FALS), with a close relative having the
disease.65 The clinical features of the two acquisition types are indistinguishable. In
1998 the El Escorial criteria was developed as the standard for classifying ALS
patients in clinical research. These criteria are based on clinical evidence of lower
and upper motor neuron involvement and represent the degree of diagnostic
certainty.52
Diagnosis
Currently there is no one hundred percent accurate, definitive test to
diagnose ALS. Diagnosis is based on a myriad of signs, symptoms, neurological and
laboratory data while simultaneously eliminating the diverse diagnostic alternatives
that mimic ALS.52 There multiple gene mutations associated with familial ALS,
several of which can be tested by commercial labs.82 The SOD1 genetic mutation
represents the only known cause in ALS development.65 However, subsequent
studies on American and British FALS patients, have shown that the SOD1 genetic
mutation only accounts for 20% of inherited ALS83,84
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Treatment
Predominant treatment consists of a variety of physical therapies and
palliative drugs. In 1995, Rilutek® (riluzole) became the first FDA approved ALS
drug.10 To date, it remains the only FDA approved ALS drug available in the United
States. Researchers believe riluzole helps protect the motor neurons from an
overproduction of glutamate; a substance involved in nervous system function
which, in excess, proves toxic to the neurons.76 Clinical trials have demonstrated a
modest two to three month extension in life expectancy.10,75,76 In America ALS is
considered an “orphan disease” in that it is a rare disorder affecting fewer than
200,000 people.10 Consequently, drug discovery remains a challenge, as
pharmaceutical companies are unlikely to make a profit from such a small market.
Hence they do not dedicate resources to costly research and drug development. In
1983, Congress passed the Orphan Drug Act providing exclusive marketing rights
and financial incentives to encourage orphan disease research.10 Despite these
initiatives, today more than 130 years later, ALS remains an incurable disease.

Primary Cause of Death
Clinical death is defined as the cessation of the two primary criteria
necessary to sustain life: blood circulation and breathing.5 Most resources available
on amyotrophic lateral sclerosis identify the leading cause of clinical death as
respiratory failure.1, 6‐8 The pathological cause of death is diagnosed through
laboratory analysis of bodily fluids and/or tissues.5 In the post mortem state this
process is known as an autopsy. To date, very little literature exists identifying the
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cause of death in ALS patients through post mortem pathological analysis. It is
estimated the autopsy rate among ALS patients is approximately four percent.6
Within the body of research that does exist, the primary cause of death in more than
70 percent of the cases is either broncho‐pneumonia or aspiration pneumonia.1,6,7,8
A twenty‐two year study following 100 ALS patients found a major discrepancy
between the clinically assessed and pathologically determined cause of death.7 A
less than 20% concordance between clinical and pathological conclusions, showed
clinical assessment not to be a reliable marker of death.7

Correlation Between Oral Health and Respiratory Disease
Recent literature supports the association between respiratory disease and
oral health and confirms the oral cavity to be a harbor of infectious respiratory
pathogens.3 In 2001, following a nine year study of 358 veterans, dental decay and
the presence of cariogenic bacteria and periodontal pathogens were shown to be
significant aspiration pneumonia risk factors.13 Another study observed 189 elderly
persons over a four year period and confirmed an association between pneumonia
and decayed teeth. In this study dependence on caregivers was also linked to
pneumonia.14 A third study linked higher plaque scores with a previous history of
respiratory tract infections.15 Periodontal disease has been moderately associated
with atherosclerosis, myocardial infarction and cardiovascular disease16 and the
risk of chronic obstructive pulmonary disease is also known to be significantly
elevated with severe periodontal attachment loss.17
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Pneumonia is defined as an inflammatory condition of the lung caused by
bacterial, viral, fungal or parasitic infections.5 The risk of pneumonia is, in part,
determined by the specific bacteria inhaled and the body’s ability to eliminate the
bacteria from the airway mucosa. To eliminate aspirated bacteria from the lower
airway, multiple defense mechanisms must function properly. Poor oral hygiene and
the presence of periodontal disease may foster oropharyngeal colonization of
respiratory pathogens which increase the probability of aspiration pneumonia,
especially in high‐risk patients.3,80The effectiveness of these mechanisms may also
be further impaired by a variety of life conditions such as advanced age, residing in a
nursing home or hospital and debilitated persons.3,

Mechanical Ventilation and Respiratory Diseases
In advanced stages of ALS the process breathing, or voluntarily exchanging
oxygen and carbon dioxide, may become difficult and often results in respiratory
distress. Symptoms often include headaches upon waking, physical exhaustion,
labored breathing, and the inability to cough or speak long sentences. Decisions
associated with ventilatory assistance become integral in ALS disease
management.24 Options include non‐invasive positive pressure ventilation (NIPPV)
and invasive ventilation. Both modalities demonstrate prolonged survival rates and
are believed to improve the patient’s overall quality of life.26‐30 Bilevel positive
pressure airway machines, otherwise known as a BiPAP, are considered a non‐
invasive form of artificial ventilation. Unlike CPAP, which provides continuous
airway pressure, the BiPAP unit provides two levels of air pressure, one on
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inhalation and another on expiration. Variant nasal and facial delivery systems are
available to assist with oxygen intake and carbon dioxide removal. There are other
forms of non‐invasive assisted ventilation available. However, in ALS patients, the
BiPAP system is most prevalent.18 Noninvasive positive pressure ventilation use in
ALS patients has been associated with prolonged survival rates.18 In recent years
nocturnal NIPPV use has become the treatment of choice for ALS patients suffering
chronic respiratory insufficiency.19 The extent of NIPPV use in amyotrophic lateral
sclerosis patients has not been widely studied.18 One source estimated successful
NIPPV use among ALS patients as high as 70% and suggested higher usage was
likely limited by improperly fitted masks.68
Approximately three to five percent of ALS patients elected to have invasive
ventilation.18,68 The immediately aforementioned source also noted more frequent
selection of invasive ventilation associated with cultural origin. For example, ALS
patients residing in Japan more frequently select invasive ventilation than those
residing in the United States.68 Mechanical ventilatory support is provided via a
tracheostomy, a surgically created opening in the trachea through which air is
forced on an individualized, timed cycle.20 This is an irreversible decision but may
exponentially prolong the patient’s life. Despite the benefit the cost of invasive
ventilation is estimated between $153K‐ $336K per year. Additionally, invasive
ventilation requires 24‐hour skilled caregiver support.19
Nosocomial bacterial pneumonia, or ventilator‐associated pneumonia (VAP),
is the most common infection reported by intensive care units (ICU).2 VAP is
associated with a seven to twenty‐one fold increase in the incidence of pneumonia2
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and accounts for 47% of all ICU patient infections.32 Twenty eight percent of
mechanically ventilated patients will develop this pneumonia resulting in an
attributable increase in morbidity and mortality.2 Another study found nosocomial
pneumonia prevalence in ICU’s ranged from 10% – 65%, with a thirteen to fifty‐five
percent fatality rate.23 Studies conducted in the 1990’s suggest ventilator‐
associated pneumonia is a vital outcome determinant in critically ill patients.23

Reduction of Respiratory Complications Through Oral Health Care Measures
Poor oral health can lead to complex medical and dental issues.31 It has also
been positively linked to an increased incidence of pneumonia in ventilated,
debilitated and other high‐risk patient groups.3,13 A significant amount of research
has been conducted, evincing consistent results, on the reduction of respiratory
complications through oral hygiene measures. Standardized oral hygiene protocols
can effectively decrease the colonization of dental bacteria associated with
respiratory pathogens that cause pneumonia.33‐39 Mechanical toothbrushing and
chlorhexidine mouthrinses were shown to be the two most effective modalities.33‐39
A 2009 study found, after implementation of an oral care protocol, a 46% reduction
in ventilator‐associated pneumonia cases during a twelve month period.36 Studies
confirmed these results not only with ICU patients but also in nursing home
residents.34
The majority of ALS patients that elect to die home is variant upon
geographical region. In Europe it approximately 52‐63% of patients die at home in
contrast to 85% electing to die at home within the United States.40‐42,68,85 One
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source estimated 85% of ALS patients die under the care of a familial caregiver.68 As
the disease progressed, the caregiver’s burden becomes enormous; exponentially
more so when mechanical ventilation is involved. Many caregivers resort to hospice
or hire skilled health care workers for assistance with the constant care that is
required. Studies evaluating nurses’ compliance of simple and CDC (Centers for
Disease Control and Prevention) oral health care guidelines found that, in the ICU,
these protocols were neither consistently nor uniformly implemented.32, 43‐49
Nurses were found to lack knowledge in recommended oral health care
procedures44,45 and discrepancies were noted among reported and actual practices
and policies.48 Despite significant evidence on the relationship between oral health
care and disease prevention, nurses generally fail to fully appreciate its
implications.49

Chapter 3: Methods and Materials
This study’s conclusions were based on the results from 60 paper surveys
distributed to existing ALS patients at ALS Association Certified Center
appointments and 61 ALS patients participating in the survey online. Participant
completion of the survey implied consent. The survey was anonymous and no
personal identifiers were collected.
ALSA Certified Center Medical Directors were sent initial contact letters
inviting their participation. Five of the thirty‐four clinics contacted participated.
Certified Center Medical Directors were asked to sign and return participation
commitment letters. Contact information regarding their Center’s designated
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survey coordinator was also collected. Participants then received a survey packet
containing 27 patient surveys with attached information cover letters.
Designated individuals were asked to distribute surveys to ALS patients, or
their primary caregiver, over the age of eighteen. As all patients attending Certified
Center multidisciplinary appointments had been previously diagnosed with
amyotrophic lateral sclerosis; therefore, patient privacy and survey recipient
selection was not an issue. Patient cover letters described the content of the survey,
investigator contact information, Institutional Review Board (IRB) approval,
informed consent and the purpose of the study. Location markers were pre‐printed
on each survey and used only to identify only the site from which the data were
collected. On a pre‐determined end date, ALS Association Certified Center
designated individuals returned all completed surveys.
Flyers promoting the identical survey in an online format were mailed to ALS
Association Executive Directors in November 2010. Directors were asked to
distribute flyers to ALS patients over age 18. ALS Association Executive Directors
disseminated flyers to ALS patients throughout their respective regions of the
United States promoting the online survey. In an attempt to prevent duplicate
responses, flyers were not sent to regions participating in the written survey.
Directors were free to disseminate flyers in electronic or paper format.
SurveyMonkey, a web‐based interface specializing in the creation and publishing of
custom web surveys, was utilized for the online effort. Parameters were set to
prohibit multiple responses from a unique IP address. The online data collection
period ran from November 2010 through January 2011.
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Demographic data including gender, onset diagnosis, type of ALS, age at
diagnosis, history of military service, intubation and ventilatory support were
collected. To determine whether patients had an increase in dental treatment needs,
patient root canal therapy and amalgam dental restorations were assessed both
prior to and since diagnosis. Participants were also questioned on the frequency
and difficulty in obtaining dental care prior to and since diagnosis. The primary
person responsible for performing oral hygiene care as well as the routinely
implemented dental hygiene regimens was also asked. Patients were questioned as
to whether they had received oral hygiene education or instruction at their ALS
Association Multidisciplinary Center appointments. A final section allowed patients
to add qualitative comments they felt were pertinent to the study.

Chapter 4: Results
The study sample was compromised of 121 diagnosed amyotrophic lateral
sclerosis patients over the age of eighteen.
Population demographics:
Gender
Gender
N=

Male
61

Female
56

Did not identify
4

Survey population age range
Age range
N=

18‐29 years
2

30‐39 years
5

40‐49 years
25

History of military service
Yes 21%;

No 79%
19

50+ years
87

Not disclosed
2

ALS Onset Type
75 participants reported bulbar onset, 80 participants limb onset.
16 respondents did not identify onset type.
Form of ALS
7% (n=8) reported familial form ALS (FALS)
73% (n=88) reported sporadic form ALS (SALS)
21% (n=25) did not identify ALS form.
Current Oral Health Care Regimes
94%

toothbrushing

44%

flossing

12%

swabbing

53%

mouthrinse

7%

utilize other mechanisms

Data Analysis
A statistical analysis of the data was formatted in the SPSS 11.5 statistical
software program and utilized standard bivariate correlations, using Pearson
correlation coefficient, to determine the level of inter‐dependence among variables.
Relevant data was analyzed using standard frequency counts, cross tabulations
(measuring inter‐variable relationships) and stepwise regression.
At the 95% statistical confidence level, the bivariate correlation analysis
showed a strong correlation between variables measuring increased difficulty in
obtaining professional dental care and 1) presence of a feeding tube, 2) patient’s
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inability to eat food through mouth and 3) caregiver(s) as primarily responsible for
dental health care.
Cross Tabulations

Frequency analysis of the same variables showed 23% of respondents have
feeding tubes, 26% are under the primary care of a caregiver, and 20% of these
individuals find it increasingly difficult to obtain professional dental care. Strong
existing correlations between these variables suggest that the majority of these
characteristics are associated with the same ALS patients.
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Currently Have Feeding Tube
90%
80%
70%
60%

No 77%

50%
40%
30%
20%
10%

Yes 23%

0%

Increased DifViculty in Obtaining Dental Care
80%
70%
60%

No 73%

50%
40%
30%
20%
10%

No reply 7%

Yes 20%

0%
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Person Responsible for Patient's Oral Care
80%
70%
60%
50%

Patient
74%

40%
30%
20%

Caregiver
26%

10%
0%

Of those ALS patients under the responsibility of a primary caregiver, 38.7%
reported an increase in difficulty obtaining dental care, compared to 13.8% of
patients capable of self‐care. This finding suggests that as the disease progresses
and the responsibility of dental health care transitions to a caregiver, the difficulty
in obtaining dental health care increases. Oral health instruction and education may
be warranted amongst both groups.
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Increased Difficulty in Obtaining Dental Care * Person Responsible for Dental Care
Cross Tabulation

The increase in difficulty in obtaining dental care variable also showed a
direct relationship with the length of time since diagnosis response. As the disease
ascends to the three‐year mark, the likelihood of the patient experiencing increased
difficulty accessing dental care also increases; a logical conclusion given the average
time elapsed from diagnosis to death is three to five years.
Increased Difficulty in Obtaining Dental Care * Length of Time Since Diagnosis
Cross Tabulation

Further analysis of patients with feeding tubes, also indicating increased
difficulty in obtaining dental care, showed a trend in the number of silver/metal,
(amalgam) fillings present prior to diagnosis in relation to the likelihood of having a
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feeding tube. 10.5% of respondents with 1‐3 fillings prior to diagnosis had a feeding
tube; that number increased to 21.1% in those with 4‐6 fillings and 52.6% among
those with 7 or more fillings. While these results indicate a potential trend, the
sample size of those with feeding tubes and prior fillings, 19 respondents, was
statistically small.
Number of Fillings * Presence of Feeding Tube – Cross Tabulation

Frequency analyses revealed an overwhelming 85% of respondents have not
received information regarding dental health care at their ALS Association
Multidisciplinary Clinic Appointments. This finding strongly advocates the inclusion
of a dental component in amyotrophic lateral sclerosis patient’s multidisciplinary
appointments.
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Received Oral Health Care Information at
Multidisciplinary Clinic Appointments
90%
80%
70%
60%

No 85%

50%
40%
30%
20%
10%

Yes 15%

0%

CHAPTER 5 – Discussion
This study surveyed 121 patients over the age of eighteen diagnosed with
ALS. The original intent was to survey patients at all of the 34 ALS Association
Certified Centers. However, many of the ALS Association Certified Center Medical
Directors were reluctant to participate without obtaining Institutional Review
Board (IRB) approval from their respective institution. Of the 34 centers invited to
participate, five gave consent. During a telephone conversation with Dr. Richard S.
Bedlack, Medical Director of Duke ALS Clinic, on 9/29/201080 he suggested
distribution of a flyer promoting the survey in an online format might produce
better compliance. An online survey was created; utilizing SurveyMonkey.com, and
amended HRRC (IRB) approval was obtained from the University of New Mexico.
Then, letters were sent to 57 regional ALS Association Chapter Executive Directors.
The survey results obtained from this method of contact proved not only easier in
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promotion and distribution but also in data collection. The demographics of this
sample population strongly resembled overall ALS population characteristics
regarding gender, age, type of ALS onset, history of military service and disease
form.
In order to expand the scope of the study several additional dental related
parameters were included. These questions inquired about the type and number of
dental restorations present in the patient’s mouth before and since diagnosis. The
two survey formats differed only in that the online survey included an additional
question, asking patients the length of time since their diagnosis. Seventy‐four
percent of the overall sample patient population responded that they were capable
of self‐care. In earlier stages of ALS when patients are less likely to be compromised
with mobility and swallowing difficulties, it was anticipated patients’ overall level of
self‐care would not only be higher but, that their oral health care regimen might also
include normal activities of self care such as brushing and flossing. With disease
progression it was anticipated oral health care responsibilities would transition to a
caregiver and obtaining professional dental health care would become more difficult.
Results from the online survey population, where length of time since diagnosis was
reported, strongly supported these correlations. The results suggested that oral
health care regimens among patients where a greater amount of time had elapsed
since diagnosis were represented in the 12% that reported swabbing in their dental
care. While swabbing alone does not provide effective oral health care, the addition
of an antimicrobial agent such as chlorhexidine has shown significant improvement
in patient periodontal pocket depths as well as plaque and calculus levels.78
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Inclusive of the entire survey population, a strong correlation existed
between the presence of a feeding tube, the inability to eat food through the mouth,
and caregiver(s) having primary responsibility of the patient’s oral health care. This
suggested that as the disease advanced and nutritional intake through the mouth
became more challenging, patients were more likely to have feeding tubes and their
daily oral health care regimen dependent on a caregiver(s). Percutaneous
Endoscopic Gastrostomy (PEG), or feeding tubes, are an effective system used to
provide patients with nutrition and hydration.71 Used in ALS patients, PEG’s, have
been shown to stabilize the weight loss typically experienced.71 However, it is also
important to recognize, even though the patient is not participating in traditional
oral food intake, their need for dental health care does not decrease. When dental
health care is neglected, bacterial pathogens within the oral cavity continue to thrive.
If not disrupted through oral health care measures, the already at‐risk patient
possesses an even greater increased risk of developing life‐threatening pneumonia.3
Almost 40% of respondents whose care is dependent on a caregiver reported
an increased difficulty in obtaining professional dental health care. In the early
stages of ALS, patients are more likely to be capable of self‐care and maintaining
routine professional dental care appointments. Within these appointments, patient
education by the dental professionals regarding the significance of oral health care
throughout the course of their disease is pivotal. As the overall health status of the
patient decreases other complications in seeking professional dental care arise.
Patient mobility, transportation, treatment scheduling, accessibility to dental offices
with wheelchair accommodations as well as symptoms of dysphagia, dyspnea,
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variant saliva levels, muscle spasticity, fatigue and other obstacles further impede
access to traditional dental care. If patients are able to obtain professional dental
care while under the supervision of a caregiver, caregiver oral health education and
instruction at these appointments becomes even more critical. Research clearly
indicates that even trained critical care nurses, with specific oral health guidelines,
do not consistently comply with recommended oral hygiene protocols.43‐46 This
supports the necessity of understanding the significance of oral health care as
essential to the ALS patient’s well‐being, not only by the patient but also the
caregiver, who may or may not be a trained skilled care worker.
Data from the online survey also suggested a relationship existed between
the length of time since diagnosis and difficulty in obtaining dental care. The
correlation between difficulty in obtaining dental care and ALS onset diagnosis type
was .034; although this leaned slightly toward limb onset, it was not a statistically
significant association. As ALS patients migrate away from individualized medical
appointments and toward multidisciplinary clinic appointments, the significance of
oral health care education and instruction is often minimized if recognized at all.
Over 85% of the total survey population reported not having received dental health
care information at their multidisciplinary clinic appointments. If the patients had
not been educated at previous professional dental care appointments, it is likely
they do not fully appreciate the association between poor oral health and the
incidence of pneumonia as well as the measures integral in mitigating these risks.
Significant research has been conducted regarding mechanically ventilated
and other high‐risk patients; this research advocates the use of oral hygiene
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protocols to reduce the overall incidence of pneumonia.33,36‐39 Oral
decontamination with 2% chlorhexidine solution alone has been strongly linked to a
reduction in bacterial colonization and incidence of ventilator associated
pneumonia (VAP) among mechanically ventilated patients.35 Limited research
exists on the prevalence of ventilator use among ALS patients, though it has been
estimated that BiPAP® use may be as high as 70%.68 Non‐invasive positive
pressure ventilation patients (BiPAP®) are also considered at high‐risk for
acquiring pneumonia due to fluctuating salivary levels, swallowing, mobility
difficulties and other oral health care considerations.80
Currently, very little information exists regarding the significance of oral
health care in amyotrophic lateral sclerosis patients. While ALS Association
multidisciplinary clinics are in an optimal position to provide these patients and
their caregivers with critical oral health care information and education, 85% of
survey respondents reported this aspect had been overlooked. The ALS Association
website does include a section entitled “Oral Care for the Patient with ALS: A Guide
for the Caregiver,” however, it does not address the association between poor oral
health and increased risk of pneumonia. Nor does it address the use of
antimicrobial agents in mitigating this risk.79 Education on the significance of oral
health care and its association with pneumonia and pneumonia related death could
be easily distributed to patients and caregivers in informative pamphlets at clinic
appointments or website links. In later disease stages, oral swabbing with
antimicrobial agents such as chlorhexidine could be implemented at a minimal cost.
The ALS patient and their caregivers do have numerous other oral health care
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options ranging from modified manual and electric toothbrushes to highly effective
suction devices as well as the antimicrobial agents already discussed. A dental
hygienist could provide valuable information during education and dental
screenings at ALS Association chapter meetings, local support groups and
multidisciplinary care visits. In many cities mobile dental units are available to
assist in both routine and critical dental health maintenance venues.
Some of the most interesting and informative data within the survey results
were the qualitative patient comments. Upon reading, it would be difficult to argue
that dental care has not been neglected. Patients and caregivers alike were
confused regarding the type of dental treatment needed as well as how and where
to obtain it. Respondents posed questions concerning the need for a general dentist
versus a specialist and whether an association existed between silver/metal
“amalgam” fillings and the acquisition of ALS. Individual responses also included
“difficult to brush,” “choking,” and “biting lip and inside jaw”. To a health care
professional, these responses were difficult to hear, especially knowing we can
educate and assist these patients during their time of greatest need.
It has been estimated over 80% of amyotrophic lateral sclerosis patients in
the United States die within their own home under the primary care of a familial
caregiver.1,42,45,68 Current research clearly shows, upon post mortem examination,
the leading causes of death in ALS patients are aspiration and broncho‐pneumonia.7
Recognizing the correlation between poor oral health and pneumonia, and the even
greater risk in those patients utilizing mechanical ventilation, one can appreciate the
significance of oral health care information and education in prevention of
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pneumonia related death.13,33‐39 Studies evaluating the knowledge and compliance
level of high‐risk and intensive care unit nurses uncovers an alarming discrepancy
between recommended oral hygiene procedures and actual performance
protocols.43‐50 Due to the substantial cost and 24‐hour care required for ALS
patients, families are often forced to rely on a variety of caregivers rather than a
single or limited number of skilled care personnel. If these medical professionals
are not cognizant of the correlation between poor oral health and risk of pneumonia,
how can we expect the average ALS patient or their caregivers to understand the
importance of an effective oral health care regimen? In conclusion, recognizing 85%
of patients reported not having received oral or dental health care information at
their ALS Association multidisciplinary clinic appointments, it is logical to assume
the majority of patients with amyotrophic lateral sclerosis and their caregivers do
not fully appreciate the significance of a proper oral health care regimen. This
demonstrates the necessity for inclusion of a dental health care component into ALS
patient multidisciplinary clinic appointments. Few documented studies have been
conducted on the oral health status of ALS patients throughout the course of their
disease. This study has validated the fact that there are many integral components
within the relationship between ALS and overall oral health. Future research should
include a prospective study evaluating the extent and specific types dental health
care interventions needed.
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APPENDIX A
Actual Qualitative Patient Survey Comments

Please add any additional comments that pertain to your experience
with ALS and Dental Considerations: (Open-Ended Response)
1. During a 30 day stain in 2 different hospitals I found dental hygiene
to the most overlooked aspect of the care I received
2. Lost filling this week, should it be put back in?
3. It is hard to hold the toothbrush as hands are weak and tire quickly.
Fingers getting weaker so much harder to floss, especially in back and it hurts to open my mouth wide. Why did you ask about filling
and root canals?
4. Started using a power toothbrush 6 mos ago.
5. choking episodes at dentist
6. I receive all my care including dental care through the VA.
7. when I went for my last cleaning and exam, I asked the hygenist to
keep my head higher than usual and they were happy to comply.
they have another patient with ALS that they are working with to
accomodate his needs
8. Dr. Jeffrey Day of Fredericksburg, Va. accepted me w/o any
hessitation. He is very mindfull of my als
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9. My wife is totally bedridden. She is unable to even sit in a
wheelchair. A little over a year ago my wife experienced severe
teeth grinding. She broke the bone holding her front bottom six
teeth. They were loose and wobbly and we were afraid that she
would aspirate her teeth. Our dentist came to the house and
removed those teeth. Since then several other teeth have
"disappeared." We used to brush her teeth and suction out the
toothpaste, but we know swab her teeth with 50% peroxide and
water daily.
10.

I have PLS.

11.

I lost 3/4 of my teeth at age 18, the remainder at age 65

12.

My dentist is not especially sympathetic to my needs. I tell him

that I do not want x-rays because I choke on the pieces that you
put in your mouth and his response is something like "well, we
need to take x-rays to spot problems with your teeth." I tell him
that I have bigger problems than my teeth, but it's in one ear and
out the other.
13.

handicap accessibility, dentists willingness to deal with the

difficulties of ALS dental care, dental offices ability to accomodate
the power wheel chair in their spaces have all made dental care
difficult for my mother. I have found that county dental clinics are
the most receptive to her with her condition....private practices
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have an array of reasons why they will not accept her...not always
sure how real those reasons are....suspect they just don`t want to
have to deal with the more complex client.
14.

Biting my lip and inside of jaw.

15.

none

16.

Should we see a Special Dentist? Or Regular one?

17.

Professional dental care not practical due to high risk of

aspirating liquids
18.

gagging is an issue

19.

Have used "Water Pic" both before & after onset.

20.

Since I thought I had a limited time left I admit I thought one

thing I could do without was dental cleaning. Wrong! After not
having any cavities as an adult I now have two small ones and I
had a decalcified spot repaired. So it is back to the dentist I am
going. My dental office was marvelous about making things as easy
for me as possible. For instance I did not have to change rooms cleaning, exams, repair, x-rays, and payment processing were all
done in same room. And there is a back exit for handicap patients
to come and go.
21.

My wife is very concerned as to whether or not amalgam fillings

containing mercury could be causing ALS in people. Is there
enough evidence that the amalgam fillings should be removed?
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22.

Difficult to locate a dentist that can accommodate a power chair.

23.

I made my first visit to a dental facility at a VA hospital last

week. I have to wait 6 wks. to get an approval from the VA to get
outside help with my teeth.
24.

did not go to the dentist before diagnoses no need. still have

not had a need to see dentist
25.

i have noticed breathing difficulties when laying prone in a dental

chair. My dentist has been very accommodating in making my
dental visit as easy and comfortable as possible.
26.

Harder to brush

27.

No dental coverage

28.

Had trouble circling (responses) wife is a dental hygienist

29.

Had dentures 20+ years

30.

My wife is a hygienist

31.

…patient receives cleanings from dentist every three months

(prior to diagnosis, every six months) patient has difficulty opening
mouth wide enough during professional cleanings, making effective
dental care challenging
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APPENDIX B
SurveyMonkey Patient Flyer
ALS Association Executive Director Participation Invitation
The first time I met “Ben” I was working as a dental hygienist in a private practice
dental office. Ben was newly diagnosed with Amyotrophic Lateral Sclerosis. We
cleaned his teeth, talked to him about his home care and sent him home like every
other patient. But as you know Ben was not like every other patient. It was not
until my Uncle was diagnosed with ALS that I fully understood the complexity of ALS
and the obstacles in obtaining dental health care.
Oral health care is an integral component to every person’s physical well being,
including those diagnosed with Amyotrophic Lateral Sclerosis (ALS). It is
speculated that as the disease advances patients with ALS often find maintaining
and receiving oral health care can quickly become a challenge.
Elaine Sanchez Dils and Susan Jones with the University of New Mexico Department
of Surgery, Division of Dental Hygiene are conducting a research study investigating
dental considerations in ALS patients. We would like to include the patients that
visit the ALS Centers in your region.
Patients, or their designated individual, would be handed a flyer asking them to
participate in an anonymous online survey about their dental experiences since
diagnosis. The survey takes about 5 minutes to complete and could be completed at
the location and time of their choice. Research study information is listed below.
The flyer is attached for printing and distribution. If you prefer hard copies, please
contact us and we will mail them directly to you. The end date for data collection is
January 31, 2011. Please feel free to contact us with any questions.
Thank you for your time and assistance,
Elaine Sanchez Dils, RDH, MA
Associate Professor
Principal Investigator
(505)272-0838
EDils@salud.unm.edu

Susan W. Jones, RDH, MSc
Master’s Degree Candidate
Research Coordinator and Co-Investigator
(505)272-4513
SWJones@salud.unm.edu

University of New Mexico IRB Approved 8/16/2010 (HRRC# 10‐200)
Federal Wide Assurance Number: 00003255
Survey link:

https://www.surveymonkey.com/s/ALSdentalresearchstudy
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APPENDIX C
SurveyMonkey Patient Flyer
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APPENDIX D
SurveyMonkey Patient Survey
(Questions numbered in survey logic format)

Den
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APPENDIX E
ALS Association Certified Center Medical Director
Participation Invitation Letter
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APPENDIX F
ALS Association Certified Center – Medical Director Participation Consent
(Recipient Name)
Director, ALS Association Certified Center
(School Name)
(Street Address)
(City, ST Zip code)
University of New Mexico
Division of Dental Hygiene
2320 Tucker NE, MSC09 5020
(505) 272-4513
Research Investigators,
This letter is to confirm that (Insert Clinic Name) is willing to allow our patients, diagnosed with Amyotrophic
Lateral Sclerosis to participate in the “Dental Considerations in Patients with Amyotrophic Lateral Sclerosis”
research study.
I am aware that by signing this letter I am acknowledging our institution and any of its employees will have
the sole responsibility of distributing and collecting the anonymous surveys. It also confirms that our
institution and its employees will not have further interaction with the research study.
We do ask if the primary point of contact will not be you, the Director of the ALS Association Certified Center,
you provide below the name, telephone number, physical address and e-mail address for the individual you
would like the investigators to directly contact.
I understand that if I have questions regarding the study or this letter, I may contact the Principal
Investigator, Elaine Sanchez Dils (505-272-0838 – EDils@salud.unm.edu), Research Coordinator and CoInvestigator, Susan Jones (505-272-4513 – SWJones@salud.unm.edu) or the University of New Mexico
Health Sciences Center Human Research Review Committee (505-272-1129).
It is the understanding and expectation that the above named research study will only commence upon
complete approval from the University of New Mexico Health Sciences Center Human Research Review
Committee.
Sincerely,
(Recipient Name)
Director, ALS Association Certified Center
(Phone number)
(E-mail address)
Alternate Contact Person Information
Name:
Telephone Number:
Address:
E-mail Address:
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APPENDIX G
ALS Patient Survey – Informed Consent Cover Letter

University of New Mexico Health Sciences Center
Informed Consent Cover Letter for Anonymous Surveys
STUDY TITLE
Dental Considerations in Patients with Amyotrophic Lateral Sclerosis
Professor Elaine Sanchez Dils RDH, MA and Susan Jones RDH, BS from the Department of Surgery, Division of Dental
Hygiene, are conducting a research study. The purpose of the study is to determine whether or not the dental needs of
Amyotrophic Lateral Sclerosis (ALS) patients are adequately being met. You are being asked to participate in this study
because of your ALS diagnosis.
Your participation will involve completion of a short written survey. The survey should take about 5 minutes to complete.
Your involvement in the study is voluntary, and you may choose not to participate. There are no names or identifying
information associated with this survey. The survey includes questions such as ”Since diagnosis how frequently has
patient received dental care?” You can refuse to answer any of the questions at any time. There are no known risks in
this study, but some individuals may experience discomfort when answering questions. All data will be kept for 5 years
in a locked file in Professor Sanchez Dils’ office and then destroyed.
The findings from this project will provide information on whether or not ALS patients would benefit from the inclusion
of a dental component to their ALS Association Certified Center appointments. If published, results will be presented in
summary form only.
If you have any questions about this research project, please feel free to call Elaine Sanchez Dils at (505)272-0838 or
Susan Jones at (505) 272-4513. If you have questions regarding your legal rights as a research subject, you may call the
UNMHSC Office of Human Research Protections at (505) 272-1129.
By returning this survey in the envelope provided, you will be agreeing to participate in the above described research
study.
Thank you for your consideration.
Sincerely,
Researcher’s Name & Title
Elaine Sanchez Dils, RDH, MA
Associate Professor

Susan Jones, RDH, BS
Masters Degree Candidate

HRRC#10-200

Version Date: 4/9/10
Page 1 of 1
OFFICIAL USE ONLY

APPROVED

8/16/10

The University of New Mexico Human Research Review Committee
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APPENDIX H
Dental Considerations in Patients with Amyotrophic Lateral Sclerosis (ALS)
Patient Survey
Location Code:
Gender of Patient: M
F
Age at time of ALS Diagnosis: _____________
ALS Onset Diagnosis:
Bulbar Onset
Limb Onset
Type of ALS:
Familial
Sporadic
Does you have a history of military service? Yes
No
Please circle answer:
1.
2.
3.
4.
5.

6.
7.

8.

Are you intubated?
Do you have a feeding tube?
Can you eat food through your mouth?
Prior to diagnosis, did you have silver
(amalgam) tooth fillings in your mouth?
Proceed to next question if you answered
‘NO’ or ‘NOT KNOWN’ to question #5.
Approximately how many silver (amalgam)
fillings were in your mouth prior to diagnosis?
Prior to diagnosis, did you have root canal
therapy on any teeth in your mouth?
Proceed to next question if you answered
‘NO’ or ‘NOT KNOWN’ to question #6.
Approximately how many root canal therapies
were done in your mouth prior to diagnosis?
Prior to diagnosis, how frequently did you
receive professional dental care?

9. Since diagnosis, how frequently have you
received professional dental care?
10. Since diagnosis, has the frequency of
professional dental care decreased?
11. Since diagnosis, have you seen an increased
difficulty accessing regular dental care?
12. Who is responsible for performing your daily
home oral care (brushing, flossing, etc)?
13. What daily home care regimes are performed
regularly (circle all that apply)?
14. Have you received information regarding oral
health or dental care during your ALS
Association Certified Center appointments?

Yes
Yes
Yes

No
No
No

Yes

No

Not
known

1‐3

4‐6

7 or
greater

Yes

No

Not
known

1‐3

4‐6

7 or
greater
2 or
more
times per
year
2 or
more
times per
year
Not
known
Not
known

Only
with pain

Rarely

Only
with pain

Rarely

Yes

No

Yes

No

Patient

Caregiver

Other

Brushing

Flossing

Swabbing

Yes

No

Not
known

Not
known
Not
known
Not
known

Rinses

*Please add any additional comments that pertain to patient experiences with ALS
and Dental considerations.
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Other

APPENDIX I
Study Collaborators
Medical Director, Zachary Simmons, M.D.
Research Coordinator, Helen (Beth) Stephens M.A, CCRC
The ALS Clinic at Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania
Medical Director, Sarah Youssof, MD
ALS Center University of New Mexico
Albuquerque, New Mexico
Medical Director, Kevin Felice, D.O.
Assistant Research Director, Lavanya Rajachandran Ph. D
Neuromuscular/ALS Clinic
Hospital for Special Care
New Britain, Connecticut
Medical Director, Ezgi Tiryaki, MD
Research Coordinator, Cindy Rhode, RN
Hennepin Faculty Associates, Multispecialty Clinic
Minneapolis Medical Research Foundation
Minneapolis, Minnesota
Medical Director, Todd Levine, M.D.
Banner Good Samaritan Medical Center
Phoenix, Arizona
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